Baylor to collaborate with Biocept on blood-based cancer tests

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

BAYLOR COLLEGE OF MEDICINE will collaborate with Biocept Inc. to develop minimally invasive blood-based tests using Biocept’s circulating tumor cell and circulating tumor DNA molecular diagnostic assay platforms to detect mutations in the estrogen receptor gene ESR1.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

I write a weekly blog for Georgetown University’s Lombardi Comprehensive Cancer Center community. Here I share an updated version of a blog post I wrote in September 2024, now supplemented by some poems I have written over the years that inspired paintings by my wife Harriet Weiner, who is a much better artist than I am a poet or writer. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login